Frederick National Laboratory for Cancer Research Revenue and Competitors

Frederick, MD USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Frederick National Laboratory for Cancer Research's estimated annual revenue is currently $105.7M per year.(i)
  • Frederick National Laboratory for Cancer Research's estimated revenue per employee is $155,000

Employee Data

  • Frederick National Laboratory for Cancer Research has 682 Employees.(i)
  • Frederick National Laboratory for Cancer Research grew their employee count by 45% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M620%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$11.3M73-10%N/AN/A
#6
$1.4M90%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7.4M4817%N/AN/A
#9
$1.1M7-53%N/AN/A
#10
$1.1M70%N/AN/A
Add Company

The Frederick National Laboratory is dedicated to improving human health through discovery and innovation in the biomedical sciences, focusing on cancer, AIDS, and emerging infectious diseases. Career opportunities: https://frederick.cancer.gov/careers

keywords:N/A

N/A

Total Funding

682

Number of Employees

$105.7M

Revenue (est)

45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Frederick National Laboratory for Cancer Research News

2022-04-20 - PREMISE Study Enrolling Children to Prevent Next Pandemic ...

The study is funded by NIH/NIAID through a subcontract with the Frederick National Laboratory for Cancer Research, operated by Leidos...

2022-04-06 - UC San Diego Joins National Trial to Explore New Vaccines ...

The trial is funded through a contract to Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research...

2022-03-30 - Study Examines Second COVID Booster to Strengthen ...

The study will include a current approved vaccine and new investigational vaccines ... to Frederick National Laboratory for Cancer Research,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A81957%N/A
#2
$75M85312%N/A
#3
$396.9M1050-2%N/A
#4
$300M10669%N/A
#5
$335.4M1331N/AN/A